Japan: Regulatory Compliance Requirements for Life Science Products

Instructor: Robert J Russell
Product ID: 702979
Training Level: Intermediate
  • Duration: 90 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-963-2556


Read Frequently Asked Questions

This training on Japanese regulatory compliance requirements will explain the country's regulations and processes (including clinical trials, filings, etc.) and use real world experiences to show how compliance issues are culturally handled for life science products in Japan.

Why Should You Attend:

If your job responsibilities require you to have knowledge of Japan’s regulatory requirements, ensuring compliance with regulatory filings and overall GCP, GMP and GLP compliance requirements or understand how best to consider Japan into your Global Business Strategy, then you will profit from attending our training.

This webinar will help you gain a comprehensive understanding of the Regulatory Structure, Clinical Trial Requirements, Marketing Authorization Procedures, Variations Processing, License Renewals and cultural working aspects within the Regulatory Environment in Japan. It will prepare you for regulatory approval processes, Agency meetings, the complexities of running studies in Japan, the importance of partner selection and will also add the cultural knowledge needed for success. The recent changes made by PMDA to be more sponsor and applicant-friendly will be reviewed. Real world experiences on actual interactions with the Agency since these changes were implemented, will also be discussed.

Course Agenda/ Areas Covered:

Part I: Japan Regulatory Compliance
  • Japan’s Regulatory Structure for the Life Science Product Industries
    • Country Healthcare System
    • Regulatory Framework: Key Agencies Involved / Reporting Structure
      • MHLW (Ministry of Health, Labour and Welfare)
      • PMDA (Pharmaceutical and Medical Device Agency)
      • MoH Consulting Committees
      • Consensus Decision-Making: Strengths, Timeline Impacts
    • Patent System
    • Pharmaceutical Affairs Law (PAL)
  • Beginning Your Company Involvement in Japan
    • Local Office and Personnel Requirements
    • Language Requirements
    • License Types
    • Options for Importers / Overseas Manufacturers
  • Objectives of the Rules Governing Medicinal Procedures
    • Life Science Regulations and the Regulatory Processes in Japa
      • Conducting Clinical Trials
      • New Product Registrations
      • Handling of Risk Management
      • Variations to Licenses
      • Post-Marketing Requirements
      • License Renewals
  • Japan’s Use of ICH Standards / Principles
    • GCP
    • GMP
    • Quality Documents and Standards
    • CTD / e-CTD Submissions
  • Starting-Up and Conducting Clinical Trials
    • Who can conduct Clinical Trials?
    • When are they needed?
    • Start-up Process & Timelines
Part II: Marketing Authorization Processes – Product Registrations / Licensing
    • Drugs
    • Medical Devices
    • Biologics
    • Combination Product
    • Drug Master File (DMF) Use in Japan
    • Labeling Requirements
    • Packaging Information Leaflets
  • Variations: Changes to Marketed Products
    • Types of Variations
    • Dossier Maintenance Expectations
  • License Renewals
    • Process and timing for Renewing Licenses
  • Comparing and Contrasting Japan’s Procedures vs. U.S. FDA
    • Comparison of Processes
    • Expected Timelines
    • Accepted Practices
  • How and When to Influence the Regulatory Process
    • Japanese Way of Thinking / Cultural Issue
    • Effective Approaches to Meet Regulators
    • The Do’s and Don’ts of Regulatory Involvement in Japan
    • Utilizing Local Regulatory Resources

Who will Benefit:

  • Clinical / Pharma & Device personnel
  • Clinical Trial Project Managers
  • Monitors / CRAs
  • QA / QC Personnel
  • Pharmacovigilance reporting personnel
  • Regulatory personnel whose responsibilities require knowledge of Japan's Regulatory and Clinical Trial environment
  • Global Supply Chain personnel
  • Manufacturing personnel
  • Global Business Development personnel

Instructor Profile:

Mr. Russell, is President and CEO of RJR Consulting, Inc, a leading Global Regulatory Consulting firm focusing on assisting the Consumer Products and Life Science Industry. Prior to founding the firm in 2000, Mr. Russell had over 27 years of experience in Product Development, Global Business Development and Regulatory Compliance for pharmaceuticals, medical devices, consumer products, food and cosmetics manufacturers. The company has offices in Columbus, Ohio, Brussels, Belgium and Buenos Aires, Argentina and several satellite offices in the Asia / Pacific region where they interact with the global Ministries of Health and product Registration Agencies. Country establishment, product licensing and maintenance and license renewals are core competencies of our speaker. Mr. Russell has received a B.S. and Chemistry.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
21 CFR Part 11 Compliance for SaaS/Cloud Applications - 80202SEM

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed